Dupuytrens contracture

Reading File
Finding Sources
Searching PubMed

Dupuytren contracture treatment

Reading File
Reading File
Reading File
Reading File
Reading File
Loading Image
Loading Image
I now have a comprehensive picture. Let me compile the full answer.

Dupuytren's Contracture (Dupuytren Disease)

Definition and Pathophysiology

Dupuytren's contracture is a benign fibroproliferative disorder of the palmar fascia (aponeurosis) causing progressive thickening, nodule formation, and eventually flexion contractures of the fingers. The key cellular player is the myofibroblast - the predominant cell type found histologically in contracted Dupuytren fascia. These cells drive:
  • An increase in the type III : type I collagen ratio
  • Contraction of palmar fascia cords pulling digits into flexion
  • Skin pitting from local fibroblastic invasion (though the process is non-malignant)
  • The tendons and joints themselves are not directly involved with Dupuytren tissue
Dupuytren disease - bilateral hand contractures showing marked finger flexion deformities
Clinical manifestation of Dupuytren disease: bilateral hand contractures. Note the amputated little finger on the left hand from advanced disease. (Rheumatology 2-Volume Set, 2022)
Dupuytren contracture - early skin pitting and cord of the ring finger
Pitting of the skin and a longitudinal cord causing MCP joint flexion in early-stage Dupuytren contracture. (Rheumatology 2-Volume Set, 2022)

Epidemiology and Risk Factors

  • Most common in White patients of Northern European descent
  • Men affected ~7x more often than women
  • Rarely seen before age 40
  • Autosomal dominant with variable penetrance (patients often identify an affected family member)
  • Associated with: tobacco use, epilepsy (and anti-epileptic drugs), chronic pulmonary disease, HIV, diabetes, alcohol use, liver disease
  • Trauma has not been proven as a causative factor
  • Occupation is NOT an established risk factor

Anatomy - Key Points

StructureInvolvement
Cleland (dorsal) ligamentsNOT involved
Grayson (volar) ligamentsInvolved
Spiral cordCauses PIP contracture; displaces neurovascular bundle centrally and superficially (at risk during surgery)
Palmar fasciaPrimary site of disease

Clinical Features

  • Fingers affected (in order of frequency): ring finger > small finger > long finger (bilateral in many patients)
  • Progression: palmar nodules (early) → longitudinal cords → flexion contractures at MCP and PIP joints
  • Usually painless (except early nodule stage can be tender)
  • The "tabletop test" (Hueston test): inability to flatten the hand against a flat surface is a classic functional finding
  • Patients also struggle putting a hand into a pocket or glove

Dupuytren Diathesis

A more severe, aggressive form. Features:
  • Earlier onset (younger patients)
  • Bilateral disease
  • Ectopic fibrosis at other sites: plantar fascia (Ledderhose disease), penile fascia (Peyronie disease), knuckle pads (Garrod pads), popliteal fascia

Staging

Tubiana Classification (based on total flexion contracture of MCP + PIP + DIP):
  • Stage 0: No deformity
  • Stage N: Nodule only, no contracture
  • Stage I: 0-45° total contracture
  • Stage II: 45-90°
  • Stage III: 90-135°
  • Stage IV: >135°

Treatment

Conservative (mild disease)

  • Local heat application, stretching exercises, protective gloves
  • Splinting does not alter disease progression
  • Intralesional corticosteroid injections may relieve pain from tender nodules

Indications for Intervention

Intervention is indicated when:
  • MCP joint flexion contracture > 30 degrees
  • Any PIP joint flexion contracture
  • Functional impairment (inability to flatten hand - positive Hueston test)

Treatment Options

MethodDescriptionOutcomesNotes
Limited fasciectomy (open)Surgical excision of diseased fascia; preferred techniqueBest long-term correctionRisk: digital nerve injury, wound breakdown, CRPS
Total palmar fasciectomyWider excision ± skin graftingFor severe diseaseHigher morbidity
Needle aponeurotomy (NA) / Percutaneous needle fasciotomyPercutaneous division of cordsEffective short-term; smaller incisionsHigh recurrence rate
Collagenase clostridium histolyticum (CCH) injectionEnzymatic digestion of cord followed by manipulationComparable to surgery for MCP correction; up to 85% MCP correction, ~60% PIP correctionSkin tears more common complication than tendon rupture; growing first-line adoption
  • Recurrence is the most common complication after fasciectomy (also the most common complication overall)
  • Other surgical complications: digital nerve injury, wound breakdown, complex regional pain syndrome (CRPS), hematoma

Important Notes on Collagenase

  • Adverse effects of CCH injection: pain, swelling, bruising (temporary)
  • Skin tears > flexor tendon rupture as complication
  • Risk of recurrence remains significant regardless of method, especially in: younger patients, bilateral disease, strong family history, fibrotic lesions elsewhere (Dupuytren diathesis)

When Full Extension May Not Be Achievable

In long-standing disease, MCP or PIP joint capsules become contracted independently of the Dupuytren tissue. In these cases, full digital extension requires extensive joint release, which carries additional neurovascular risk.

Recent Evidence (2023-2026)

Recent systematic reviews provide updated guidance:

Key Exam Points Summary

FactAnswer
Predominant cell typeMyofibroblast
Collagen ratio changeType III : I increased
Ligament involvedGrayson (volar) - NOT Cleland
Most common finger affectedRing finger
Surgical indication (MCP)>30° contracture
Any PIP contractureIndication for surgery
Gold standard surgeryOpen limited fasciectomy
Most common complicationRecurrence
Test for indicationHueston (tabletop) test
Structure at risk in surgeryNeurovascular bundle (displaced by spiral cord)
  • Miller's Review of Orthopaedics, 9th Edition, p. block5
  • Rheumatology, 2-Volume Set (2022, Elsevier), p. 725
This is a shared conversation. Sign in to Orris to start your own chat.